| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.07e-12 | 37 | 76 | 8 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.34e-12 | 38 | 76 | 8 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 6.27e-08 | 11 | 76 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | peptidase activity | USP36 ERVK-6 AGBL4 MASP1 FOLH1 ERVK-8 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ERVK-10 MMP7 ERVK-24 USP15 | 1.50e-07 | 654 | 76 | 14 | GO:0008233 |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 1.88e-07 | 14 | 76 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 2.77e-07 | 37 | 76 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 5.55e-07 | 79 | 76 | 6 | GO:0004521 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 MASP1 ERVK-8 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ERVK-10 MMP7 ERVK-24 USP15 | 6.62e-07 | 430 | 76 | 11 | GO:0004175 |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 8.48e-07 | 46 | 76 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.10e-06 | 21 | 76 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.30e-05 | 38 | 76 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 1.32e-05 | 136 | 76 | 6 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 1.32e-05 | 136 | 76 | 6 | GO:0004519 | |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 AGBL4 UBR4 ERVK-8 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ZMIZ1 MMP7 ERVK-24 | 1.29e-04 | 891 | 76 | 12 | GO:0008270 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | DDX19B ERVK-6 ERCC3 AGO4 GARS1 ERVK-8 NUDT16L1 ERVK-7 ERVK-10 ARID1A | 1.61e-04 | 645 | 76 | 10 | GO:0140640 |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 1.85e-04 | 417 | 76 | 8 | GO:0140098 | |
| GeneOntologyMolecularFunction | nuclease activity | 2.50e-04 | 231 | 76 | 6 | GO:0004518 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 4.89e-04 | 262 | 76 | 6 | GO:0140097 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 5-kinase activity | 5.06e-04 | 9 | 76 | 2 | GO:0016308 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.04e-03 | 303 | 76 | 6 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.32e-03 | 562 | 76 | 8 | GO:0003712 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ERVK-6 AGBL4 UBR4 ERVK-8 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ZMIZ1 MMP7 ERVK-24 | 1.69e-03 | 1189 | 76 | 12 | GO:0046914 |
| GeneOntologyMolecularFunction | structural molecule activity | THSD4 ERVK-6 CRYGS ERVK-8 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-24 | 1.97e-03 | 891 | 76 | 10 | GO:0005198 |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 2.71e-03 | 152 | 76 | 4 | GO:0016779 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | PKMYT1 ERVK-6 ITPKC ERVK-8 PIP5K1B ERVK-7 ERVK-10 LTK PIP5K1C TTK | 2.86e-03 | 938 | 76 | 10 | GO:0016772 |
| GeneOntologyMolecularFunction | K48-linked deubiquitinase activity | 2.86e-03 | 21 | 76 | 2 | GO:1990380 | |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 4.38e-03 | 26 | 76 | 2 | GO:0052742 | |
| GeneOntologyBiologicalProcess | DNA integration | 1.19e-07 | 13 | 76 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 7.11e-07 | 85 | 76 | 6 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 7.11e-07 | 85 | 76 | 6 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 9.34e-07 | 89 | 76 | 6 | GO:0006949 | |
| GeneOntologyBiologicalProcess | DNA repair | ERVK-6 SUPT20HL1 ARID1B ERCC3 SUPT16H ERVK-8 SUPT20HL2 NUDT16L1 ERVK-7 ERVK-10 ARID1A | 2.42e-05 | 648 | 76 | 11 | GO:0006281 |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 2.93e-05 | 48 | 76 | 4 | GO:0000731 | |
| GeneOntologyBiologicalProcess | C-terminal protein deglutamylation | 1.99e-04 | 6 | 76 | 2 | GO:0035609 | |
| GeneOntologyBiologicalProcess | embryo development | AGBL4 SUPT20HL1 ERCC3 HOXC9 AMOT ETS2 LRP4 SUPT20HL2 TAB1 ZMIZ1 MYO15A ARID1A PRRC2B ZIC1 CDON | 2.06e-04 | 1437 | 76 | 15 | GO:0009790 |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 2.51e-04 | 83 | 76 | 4 | GO:0006278 | |
| GeneOntologyBiologicalProcess | negative regulation of meiotic cell cycle phase transition | 2.78e-04 | 7 | 76 | 2 | GO:1901994 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | SUPT20HL1 HOXC9 AMOT ETS2 LRP4 SUPT20HL2 MYO15A ARID1A ZIC1 CDON | 2.78e-04 | 713 | 76 | 10 | GO:0048598 |
| GeneOntologyBiologicalProcess | viral process | 3.05e-04 | 464 | 76 | 8 | GO:0016032 | |
| GeneOntologyCellularComponent | npBAF complex | 1.57e-05 | 14 | 75 | 3 | GO:0071564 | |
| GeneOntologyCellularComponent | nBAF complex | 2.40e-05 | 16 | 75 | 3 | GO:0071565 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 1.68e-04 | 30 | 75 | 3 | GO:0016514 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 3.96e-04 | 96 | 75 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | bBAF complex | 5.61e-04 | 10 | 75 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | uropod | 1.12e-03 | 14 | 75 | 2 | GO:0001931 | |
| GeneOntologyCellularComponent | brahma complex | 1.12e-03 | 14 | 75 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | ATPase complex | 1.20e-03 | 129 | 75 | 4 | GO:1904949 | |
| GeneOntologyCellularComponent | cell trailing edge | 1.29e-03 | 15 | 75 | 2 | GO:0031254 | |
| MousePheno | abnormal cardiovascular development | SUPT20HL1 ANGPT2 FOLH1 AMOT UBR4 ETS2 SUPT20HL2 TAB1 WDFY3 ZMIZ1 ARID1A PIP5K1C IL6ST PRRC2B | 1.01e-05 | 802 | 63 | 14 | MP:0002925 |
| MousePheno | abnormal blood vessel morphology | THSD4 SUPT20HL1 ARID1B ANGPT2 NKX2-1 FOLH1 AMOT UBR4 ETS2 SUPT20HL2 TAB1 WDFY3 ZMIZ1 MMP7 ARID1A PIP5K1C SS18 PRRC2B CDON | 1.55e-05 | 1472 | 63 | 19 | MP:0001614 |
| MousePheno | abnormal pleural cavity morphology | 2.00e-05 | 2 | 63 | 2 | MP:0012684 | |
| MousePheno | abnormal vascular development | SUPT20HL1 ANGPT2 FOLH1 AMOT UBR4 ETS2 SUPT20HL2 ZMIZ1 ARID1A PIP5K1C PRRC2B | 2.65e-05 | 542 | 63 | 11 | MP:0000259 |
| MousePheno | abnormal vitelline vasculature morphology | 8.62e-05 | 235 | 63 | 7 | MP:0003229 | |
| Domain | BAF250_C | 1.31e-05 | 2 | 68 | 2 | IPR033388 | |
| Domain | BAF250_C | 1.31e-05 | 2 | 68 | 2 | PF12031 | |
| Domain | BAF250/Osa | 1.31e-05 | 2 | 68 | 2 | IPR021906 | |
| Domain | SSXT | 3.91e-05 | 3 | 68 | 2 | PF05030 | |
| Domain | SS18_fam | 3.91e-05 | 3 | 68 | 2 | IPR007726 | |
| Domain | PInositol-4-P-5-kinase | 2.71e-04 | 7 | 68 | 2 | IPR023610 | |
| Domain | PIPKc | 3.61e-04 | 8 | 68 | 2 | SM00330 | |
| Domain | - | 3.61e-04 | 8 | 68 | 2 | 3.30.800.10 | |
| Domain | PIP5K | 3.61e-04 | 8 | 68 | 2 | PF01504 | |
| Domain | PIPK | 3.61e-04 | 8 | 68 | 2 | PS51455 | |
| Domain | PInositol-4-P-5-kinase_N | 3.61e-04 | 8 | 68 | 2 | IPR027484 | |
| Domain | PInositol-4-P-5-kinase_C | 3.61e-04 | 8 | 68 | 2 | IPR027483 | |
| Domain | - | 3.61e-04 | 8 | 68 | 2 | 3.30.810.10 | |
| Domain | PInositol-4-P-5-kinase_core | 3.61e-04 | 8 | 68 | 2 | IPR002498 | |
| Domain | FN3 | 5.68e-04 | 185 | 68 | 5 | SM00060 | |
| Domain | FN3 | 7.90e-04 | 199 | 68 | 5 | PS50853 | |
| Domain | FN3_dom | 9.84e-04 | 209 | 68 | 5 | IPR003961 | |
| Domain | - | 1.33e-03 | 15 | 68 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 1.33e-03 | 15 | 68 | 2 | SM00501 | |
| Domain | ARID_dom | 1.33e-03 | 15 | 68 | 2 | IPR001606 | |
| Domain | ARID | 1.33e-03 | 15 | 68 | 2 | PS51011 | |
| Domain | ARID | 1.33e-03 | 15 | 68 | 2 | PF01388 | |
| Domain | fn3 | 2.89e-03 | 162 | 68 | 4 | PF00041 | |
| Domain | HormR | 3.71e-03 | 25 | 68 | 2 | SM00008 | |
| Domain | ETS_DOMAIN_1 | 4.64e-03 | 28 | 68 | 2 | PS00345 | |
| Domain | ETS_DOMAIN_2 | 4.64e-03 | 28 | 68 | 2 | PS00346 | |
| Domain | ETS | 4.64e-03 | 28 | 68 | 2 | SM00413 | |
| Domain | Ets_dom | 4.64e-03 | 28 | 68 | 2 | IPR000418 | |
| Domain | ETS_DOMAIN_3 | 4.64e-03 | 28 | 68 | 2 | PS50061 | |
| Domain | Ets | 4.64e-03 | 28 | 68 | 2 | PF00178 | |
| Domain | HRM | 4.64e-03 | 28 | 68 | 2 | PF02793 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 1.82e-05 | 137 | 57 | 6 | M48232 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 2.40e-05 | 42 | 57 | 4 | M48237 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 3.97e-05 | 95 | 57 | 5 | M48268 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 2.10e-11 | 4 | 76 | 4 | 10469592 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 3.41e-11 | 94 | 76 | 8 | 21542922 | |
| Pubmed | 3.41e-11 | 12 | 76 | 5 | 14557543 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.05e-10 | 5 | 76 | 4 | 12629516 | |
| Pubmed | 2.82e-08 | 15 | 76 | 4 | 23785148 | ||
| Pubmed | 4.00e-08 | 4 | 76 | 3 | 7983737 | ||
| Pubmed | 6.29e-08 | 18 | 76 | 4 | 18664271 | ||
| Pubmed | 2.00e-07 | 6 | 76 | 3 | 15063128 | ||
| Pubmed | 3.49e-07 | 7 | 76 | 3 | 23540691 | ||
| Pubmed | USP36 ARID1B DNAJA2 SS18L1 IL21R SUPT16H LRP4 WDFY3 LTK ARID1A SS18 ABCA7 PRRC2B | 8.36e-07 | 1116 | 76 | 13 | 31753913 | |
| Pubmed | 1.19e-06 | 10 | 76 | 3 | 12970426 | ||
| Pubmed | 2.17e-06 | 12 | 76 | 3 | 11734557 | ||
| Pubmed | Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome. | 3.59e-06 | 14 | 76 | 3 | 36289231 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 3.98e-06 | 724 | 76 | 10 | 36232890 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 34386776 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 23202128 | ||
| Pubmed | ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells. | 4.71e-06 | 2 | 76 | 2 | 23076342 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 33890484 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 19549683 | ||
| Pubmed | Cross-Talk between Shp1 and PIPKIγ Controls Leukocyte Recruitment. | 4.71e-06 | 2 | 76 | 2 | 26101325 | |
| Pubmed | ARID1B is a specific vulnerability in ARID1A-mutant cancers. | 4.71e-06 | 2 | 76 | 2 | 24562383 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 9060628 | ||
| Pubmed | Activated Ets2 is required for persistent inflammatory responses in the motheaten viable model. | 4.71e-06 | 2 | 76 | 2 | 15240733 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 32203187 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 4.71e-06 | 2 | 76 | 2 | 9460924 | |
| Pubmed | Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis. | 4.71e-06 | 2 | 76 | 2 | 37611161 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 32791957 | ||
| Pubmed | ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma. | 4.71e-06 | 2 | 76 | 2 | 29890703 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 24788099 | ||
| Pubmed | [Expression and clinical significance of Ang-2 and MMP-7 in laryngeal carcinoma]. | 4.71e-06 | 2 | 76 | 2 | 20359117 | |
| Pubmed | Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers. | 4.71e-06 | 2 | 76 | 2 | 28967863 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 33052929 | ||
| Pubmed | Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas. | 4.71e-06 | 2 | 76 | 2 | 27562491 | |
| Pubmed | Common origin of the human synovial sarcoma associated SS18 and SS18L1 gene loci. | 4.71e-06 | 2 | 76 | 2 | 16484776 | |
| Pubmed | 1.29e-05 | 65 | 76 | 4 | 26655900 | ||
| Pubmed | 1.30e-05 | 21 | 76 | 3 | 27894818 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 33432679 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 21647563 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 34044070 | ||
| Pubmed | Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes. | 1.41e-05 | 3 | 76 | 2 | 26716708 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 14681219 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 10516026 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 28441416 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 9971820 | ||
| Pubmed | Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. | 1.41e-05 | 3 | 76 | 2 | 22426308 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 38485250 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 24382590 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 24220028 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 16926188 | ||
| Pubmed | PIP5KIβ selectively modulates apical endocytosis in polarized renal epithelial cells. | 1.41e-05 | 3 | 76 | 2 | 23342003 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 22942276 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 11435705 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 34512623 | ||
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 1.72e-05 | 23 | 76 | 3 | 30962207 | |
| Pubmed | OTUB1 modulates c-IAP1 stability to regulate signalling pathways. | 1.96e-05 | 24 | 76 | 3 | 23524849 | |
| Pubmed | Zic1 and Zic3 regulate medial forebrain development through expansion of neuronal progenitors. | 2.23e-05 | 25 | 76 | 3 | 17507568 | |
| Pubmed | 2.62e-05 | 396 | 76 | 7 | 26687479 | ||
| Pubmed | 2.69e-05 | 549 | 76 | 8 | 38280479 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PKMYT1 LRFN1 UBR4 ADGRB2 LRP4 WDFY3 LTK ARID1A PIP5K1C ABCA7 PRRC2B | 2.75e-05 | 1105 | 76 | 11 | 35748872 |
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 24244464 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 18188447 | ||
| Pubmed | Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms. | 2.82e-05 | 4 | 76 | 2 | 26637798 | |
| Pubmed | Identification and characterization of a phosphoinositide phosphate kinase homolog. | 2.82e-05 | 4 | 76 | 2 | 14701839 | |
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 9535851 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 28863077 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 10800945 | ||
| Pubmed | Two related ARID family proteins are alternative subunits of human SWI/SNF complexes. | 2.82e-05 | 4 | 76 | 2 | 15170388 | |
| Pubmed | Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein. | 2.82e-05 | 4 | 76 | 2 | 11988099 | |
| Pubmed | 2.82e-05 | 27 | 76 | 3 | 29374058 | ||
| Pubmed | 3.16e-05 | 28 | 76 | 3 | 21658586 | ||
| Pubmed | 3.52e-05 | 29 | 76 | 3 | 19279220 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | PKMYT1 STRN ARID1B DNAJA2 GARS1 ARID1A SS18 TTK NXF1 PCMT1 PRRC2B | 4.10e-05 | 1155 | 76 | 11 | 20360068 |
| Pubmed | Recent advances in understanding chromatin remodeling by Swi/Snf complexes. | 4.69e-05 | 5 | 76 | 2 | 12672490 | |
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 4.69e-05 | 5 | 76 | 2 | 11401426 | |
| Pubmed | The lipid kinase PIP5K1C regulates pain signaling and sensitization. | 4.69e-05 | 5 | 76 | 2 | 24853942 | |
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 12200431 | ||
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 38489371 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 5.10e-05 | 440 | 76 | 7 | 34244565 | |
| Pubmed | 5.71e-05 | 34 | 76 | 3 | 20181579 | ||
| Pubmed | Branches of the B cell antigen receptor pathway are directed by protein conduits Bam32 and Carma1. | 7.03e-05 | 6 | 76 | 2 | 14614850 | |
| Pubmed | 7.03e-05 | 6 | 76 | 2 | 28581524 | ||
| Pubmed | 7.03e-05 | 6 | 76 | 2 | 16230384 | ||
| Pubmed | Numerous BAF complex genes are mutated in Coffin-Siris syndrome. | 7.03e-05 | 6 | 76 | 2 | 25081545 | |
| Pubmed | Origin and molecular specification of globus pallidus neurons. | 7.03e-05 | 6 | 76 | 2 | 20181580 | |
| Pubmed | 7.03e-05 | 6 | 76 | 2 | 20841379 | ||
| Pubmed | 7.73e-05 | 638 | 76 | 8 | 31182584 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | PKMYT1 DDX19B STRN DNAJA2 UBR4 GARS1 SUPT16H NUDT16L1 TAB1 SPATS2 TTK PRRC2B | 9.29e-05 | 1496 | 76 | 12 | 32877691 |
| Pubmed | 9.83e-05 | 7 | 76 | 2 | 15018809 | ||
| Pubmed | 9.83e-05 | 7 | 76 | 2 | 16647303 | ||
| Pubmed | 1.08e-04 | 42 | 76 | 3 | 19449303 | ||
| Pubmed | 1.08e-04 | 42 | 76 | 3 | 26166575 | ||
| Pubmed | Boc modifies the holoprosencephaly spectrum of Cdo mutant mice. | 1.31e-04 | 8 | 76 | 2 | 21183473 | |
| Pubmed | 1.31e-04 | 8 | 76 | 2 | 21802298 | ||
| Pubmed | Diverse alternative back-splicing and alternative splicing landscape of circular RNAs. | 1.31e-04 | 8 | 76 | 2 | 27365365 | |
| Pubmed | 1.31e-04 | 8 | 76 | 2 | 15046600 | ||
| Pubmed | 1.31e-04 | 8 | 76 | 2 | 20599239 | ||
| Pubmed | 1.31e-04 | 8 | 76 | 2 | 20622009 | ||
| Pubmed | 1.31e-04 | 8 | 76 | 2 | 9681824 | ||
| Pubmed | USP15 potentiates NF-κB activation by differentially stabilizing TAB2 and TAB3. | 1.31e-04 | 8 | 76 | 2 | 31903660 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.42e-04 | 361 | 76 | 6 | 26167880 | |
| Interaction | ERG interactions | 8.69e-08 | 223 | 71 | 9 | int:ERG | |
| Interaction | PAX8 interactions | 2.61e-06 | 111 | 71 | 6 | int:PAX8 | |
| Interaction | ESPL1 interactions | 9.79e-06 | 81 | 71 | 5 | int:ESPL1 | |
| Interaction | DPF3 interactions | 2.13e-05 | 95 | 71 | 5 | int:DPF3 | |
| Interaction | SMARCC2 interactions | 3.33e-05 | 353 | 71 | 8 | int:SMARCC2 | |
| Interaction | SHC1 interactions | 3.98e-05 | 362 | 71 | 8 | int:SHC1 | |
| Interaction | BRD9 interactions | 5.80e-05 | 117 | 71 | 5 | int:BRD9 | |
| Interaction | SMARCC1 interactions | 6.03e-05 | 384 | 71 | 8 | int:SMARCC1 | |
| Interaction | SMARCE1 interactions | 6.74e-05 | 287 | 71 | 7 | int:SMARCE1 | |
| Interaction | ETS1 interactions | 6.81e-05 | 121 | 71 | 5 | int:ETS1 | |
| Interaction | TCF7 interactions | 7.05e-05 | 23 | 71 | 3 | int:TCF7 | |
| Interaction | CD3E interactions | 8.64e-05 | 66 | 71 | 4 | int:CD3E | |
| Interaction | BICRA interactions | 9.17e-05 | 67 | 71 | 4 | int:BICRA | |
| Interaction | DDX11 interactions | 9.72e-05 | 68 | 71 | 4 | int:DDX11 | |
| Interaction | GCM1 interactions | 9.72e-05 | 68 | 71 | 4 | int:GCM1 | |
| Interaction | ETV4 interactions | 1.03e-04 | 69 | 71 | 4 | int:ETV4 | |
| Interaction | WWTR1 interactions | 1.16e-04 | 422 | 71 | 8 | int:WWTR1 | |
| Interaction | GM2A interactions | 1.42e-04 | 75 | 71 | 4 | int:GM2A | |
| GeneFamily | AT-rich interaction domain containing | 6.51e-04 | 15 | 46 | 2 | 418 | |
| GeneFamily | Fibronectin type III domain containing | 7.22e-04 | 160 | 46 | 4 | 555 | |
| GeneFamily | ETS transcription factor family | 2.30e-03 | 28 | 46 | 2 | 534 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 5.11e-03 | 42 | 46 | 2 | 602 | |
| Coexpression | GSE27896_HDAC6_KO_VS_WT_TREG_UP | 6.52e-06 | 176 | 68 | 6 | M8248 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | THSD4 YIPF5 SDK2 SHISA2 WDFY3 ZMIZ1 SPATS2 ARID1A USP15 TTK PRRC2B CDON | 9.88e-06 | 1009 | 68 | 12 | M157 |
| Coexpression | GSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP | 1.35e-05 | 200 | 68 | 6 | M9686 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 2.06e-05 | 323 | 68 | 7 | M9150 | |
| Coexpression | SCIBETTA_KDM5B_TARGETS_DN | 5.38e-05 | 79 | 68 | 4 | M6787 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.07e-07 | 186 | 68 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.07e-07 | 186 | 68 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.89e-06 | 168 | 68 | 5 | e20e1936573fdde78426d7a4eb45c458d5c4dbb4 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.89e-06 | 168 | 68 | 5 | 16b517e3159ad6e6d25fd48f7d5f46e77b2b318d | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.59e-06 | 177 | 68 | 5 | ac8f774596068e66c0a9ea8a318be0ce5f5df834 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.59e-06 | 177 | 68 | 5 | d9c4a93b0e04a13bf39992dd1c1ec8df2c5f89fe | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.17e-06 | 184 | 68 | 5 | 0ba243cbf69b4fe6ae100a7f0314317bec38026c | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 9.17e-06 | 184 | 68 | 5 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.17e-06 | 184 | 68 | 5 | 2a8338e94937686a148b5433515700ca0f674058 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.91e-06 | 187 | 68 | 5 | 11670a85db87cbb3e78022a589632173604b0940 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.91e-06 | 187 | 68 | 5 | 0277d4e54bd4d48f30241c2951a569209423fee8 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.07e-05 | 190 | 68 | 5 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-05 | 195 | 68 | 5 | 6617abca0009ad3d8731f515f91ab275f9ea4c40 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-05 | 195 | 68 | 5 | fc0ae145a2118df7cbbc9ac4ca9dc12d26c087c4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-05 | 196 | 68 | 5 | 82b117be41f2e7d677a42d2a5198726eeccb16d0 | |
| ToppCell | Sepsis-URO|Sepsis / Disease, condition lineage and cell class | 1.34e-05 | 199 | 68 | 5 | 8e6dac82d1d0e759cd567f9c95b70cb4801d7caf | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.44e-05 | 135 | 68 | 4 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.00e-04 | 158 | 68 | 4 | 17a13c5719eb363f2eb8f1d4e171429c6a1ce1e9 | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.00e-04 | 158 | 68 | 4 | 1397078f909338fa5fa3b01748db891e5e3fc9e7 | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.00e-04 | 158 | 68 | 4 | e5451cfe67e882eb0c1eca287740f8ab75370abc | |
| ToppCell | Mild_COVID-19-B_cell-Plasmablast|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.10e-04 | 162 | 68 | 4 | b67f6fb3d7f6093c8ef02398ff8fea4d0fb41a3b | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 164 | 68 | 4 | b0ed8cb6000ce8bf94444307e4b7b3574fa3fab2 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 164 | 68 | 4 | 3aea6207a011ad55a1aeb2ed9fb54d31b23694b5 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-04 | 172 | 68 | 4 | d65ffff3e341af34a043a0d802d7ba4b69de36e9 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l9|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.42e-04 | 173 | 68 | 4 | 15a77f6aac968b7a1afea4f60aedbb95b9d0f765 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.48e-04 | 175 | 68 | 4 | a84965d28438a4228d841b357c2cd75cf4b59a63 | |
| ToppCell | facs-Heart-RV-18m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 176 | 68 | 4 | 3e7647364c13beade9ca278c7ce8e89546e0b060 | |
| ToppCell | facs-Heart-RV-18m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 176 | 68 | 4 | a55572470de6af6cbf29ed4f785fdca62d24cd23 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-8|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.55e-04 | 177 | 68 | 4 | 066e7500e7bdde88a7914f50a4661d8adf6db925 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.65e-04 | 180 | 68 | 4 | 8e96f8646c002768b272359af485dc0ab57e0ccd | |
| ToppCell | Posterior_cortex-Macroglia-OLIGODENDROCYTE-O1-Tfr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.68e-04 | 70 | 68 | 3 | b159435487b90331d2d276f182fc8aedf88d612c | |
| ToppCell | Posterior_cortex-Macroglia-OLIGODENDROCYTE-O1-Tfr-Oligodendrocyte.Tfr.Il33_(Il33)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.68e-04 | 70 | 68 | 3 | 7e09547b73789d789c3c464689f7998445830238 | |
| ToppCell | Posterior_cortex-Macroglia-OLIGODENDROCYTE-O1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.68e-04 | 70 | 68 | 3 | b486f7fe68743e3385809cfd64512da2f31074df | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gad2-Fos_(IEG_state,_GABAergic)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.68e-04 | 70 | 68 | 3 | e1ac00f4a519b6ada89f591e549874bd3eed0ca1 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gad2-Fos_(IEG_state,_GABAergic)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.68e-04 | 70 | 68 | 3 | 27e12c0f43a996bcbed285c5ee668bef5a786d80 | |
| ToppCell | Posterior_cortex-Macroglia-OLIGODENDROCYTE-O1-Tfr-Oligodendrocyte.Tfr.Il33_(Il33)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.68e-04 | 70 | 68 | 3 | 8ee9c9c78eec9dc0cec364ee7c9bc6f34d37de76 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gad2-Fos_(IEG_state,_GABAergic)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.68e-04 | 70 | 68 | 3 | b6815131e87e81c10e65bc398a84dab5a74b32ac | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.80e-04 | 184 | 68 | 4 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-04 | 184 | 68 | 4 | 8fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-04 | 185 | 68 | 4 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-04 | 185 | 68 | 4 | 4d0f3d86fab02c80093e62cb0c79c586c13c5412 | |
| ToppCell | Tuft|World / Class top | 1.87e-04 | 186 | 68 | 4 | f4d83f15ab7b49c0920a322cd832413ece7c9948 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.91e-04 | 187 | 68 | 4 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | Tuft-tuft-2|World / Class top | 1.91e-04 | 187 | 68 | 4 | 4ec6eee866619dfe13c84f5d2e812bb380d37139 | |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|Mesenchymal_cells / Lineage and Cell class | 1.91e-04 | 187 | 68 | 4 | e899b906409f3fad69cb3d3c6432c3fd862ae3c1 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.95e-04 | 188 | 68 | 4 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 1.99e-04 | 189 | 68 | 4 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-04 | 189 | 68 | 4 | 38acb307907fde68b992057714448c1561d69ee3 | |
| ToppCell | IPF-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 2.03e-04 | 190 | 68 | 4 | 4f15842b424eefadbfe451875e517cf70e29607f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.07e-04 | 191 | 68 | 4 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | Severe-Treg|World / Disease group and Cell class | 2.07e-04 | 191 | 68 | 4 | 0a80b8c317e8da4d4722cfd13cdabc32b58021eb | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 2.07e-04 | 191 | 68 | 4 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 2.11e-04 | 192 | 68 | 4 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.11e-04 | 192 | 68 | 4 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 2.11e-04 | 192 | 68 | 4 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-04 | 193 | 68 | 4 | 8646e573f2d2ff175f3d02bfdf214e65f3b614d3 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 2.16e-04 | 193 | 68 | 4 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-04 | 193 | 68 | 4 | ba484fa1f290a92ae02475a4c468b4ac840c133e | |
| ToppCell | AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.16e-04 | 193 | 68 | 4 | 8187f976fd2d11fad3286690f1a046e894772220 | |
| ToppCell | (07)_Brush|World / shred by cell type and Timepoint | 2.16e-04 | 193 | 68 | 4 | 9af9d22a130ff97a9c37142a65e841b056d08640 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-04 | 194 | 68 | 4 | 52aebb0b563e2c2058e7f0554ae870e47692b163 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 2.20e-04 | 194 | 68 | 4 | 8dcde77767b23e75360adb316cdccf56a00e3726 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.20e-04 | 194 | 68 | 4 | cbc4b6422777117e4123804168c23f19d1b79486 | |
| ToppCell | Severe-Treg|Severe / Disease group and Cell class | 2.20e-04 | 194 | 68 | 4 | 7d232d87262ec5f505901345da5113cabf821321 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-04 | 194 | 68 | 4 | bd06e2b8d8c06cddf2e4f58849b86e09013acae1 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.24e-04 | 195 | 68 | 4 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.24e-04 | 195 | 68 | 4 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.24e-04 | 195 | 68 | 4 | b0cea3f4e59635913d243612f2e8cf4c7b34e726 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-04 | 195 | 68 | 4 | d9694db6bf239636d1335016878c98f6ee2eb0eb | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-04 | 195 | 68 | 4 | 3e24570def013d5b0b1ef1d7a5ced7dfd922590b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-04 | 195 | 68 | 4 | 37aa6e4123d37de4de42ca68d3020f2a7686ce02 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 2.29e-04 | 196 | 68 | 4 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | AT1|World / shred by cell class for parenchyma | 2.29e-04 | 196 | 68 | 4 | 2bc487f8a109a6961ebff111dec79c2227ea60ac | |
| ToppCell | ASK440-Epithelial-Type_2|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.29e-04 | 196 | 68 | 4 | 754b4202b617165c6994a0b5a9b1e486dccdd44d | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-04 | 196 | 68 | 4 | 9d267dd293fde05f04febc0a9d15776c5b782a1c | |
| ToppCell | mLN-T_cell-Treg|T_cell / Region, Cell class and subclass | 2.33e-04 | 197 | 68 | 4 | 3779489d57ebda33277c79cba037f4c73128c8ba | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.33e-04 | 197 | 68 | 4 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | ASK440-Epithelial-Type_2|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.33e-04 | 197 | 68 | 4 | 08d5bbeb77a4152af1c783bc958afcae24667767 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.38e-04 | 198 | 68 | 4 | 55e583321f60c95898d93cd0d2615c6692db52ec | |
| ToppCell | AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.38e-04 | 198 | 68 | 4 | 893036558a9ad86b57f9e735df35812e9d18739e | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.38e-04 | 198 | 68 | 4 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.38e-04 | 198 | 68 | 4 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.42e-04 | 199 | 68 | 4 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.42e-04 | 199 | 68 | 4 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.42e-04 | 199 | 68 | 4 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.42e-04 | 199 | 68 | 4 | e19b296d583f8bad3b66ee998a8153634d6fe09e | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-04 | 199 | 68 | 4 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.42e-04 | 199 | 68 | 4 | a38a981cffa61c8444a980916de7414e689a1b63 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-AT2|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.42e-04 | 199 | 68 | 4 | 5323d49d3be980605b3e609b7f03bddba6e50e8a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.42e-04 | 199 | 68 | 4 | 667b8b47a5b388506e3177b46747267fad8024f6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.42e-04 | 199 | 68 | 4 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.42e-04 | 199 | 68 | 4 | 121de4e02585de3a3010398387c523bacf8ce546 | |
| ToppCell | Biopsy_IPF-Epithelial-AT2|Biopsy_IPF / Sample group, Lineage and Cell type | 2.42e-04 | 199 | 68 | 4 | c841d475703d3489161fb7904526bd7563d5fb0f | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.42e-04 | 199 | 68 | 4 | 801887db51ac5dc5b068808ff75e3a46643398e9 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-OPC_related|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.47e-04 | 200 | 68 | 4 | 439265194cb08d1373296bf8684cc31294cecb20 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.47e-04 | 200 | 68 | 4 | 3c251ad03fbbdae91dfd9037880ba43adbb03807 | |
| ToppCell | distal-Epithelial-Signaling_Alveolar_Epithelial_Type_2-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.47e-04 | 200 | 68 | 4 | f47bb79202a59404e4916993a1f59cffcf710320 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.47e-04 | 200 | 68 | 4 | c905451425d1c24773bb0ca69bcf0309b277d2f1 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 200 | 68 | 4 | 23088edc62bf7d4db890937bfd7925dc316fcc76 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.47e-04 | 200 | 68 | 4 | acc771a902cf2f060c3eb9aedb72a256f5778a6c | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 5.21e-05 | 5 | 68 | 2 | C3281201 | |
| Disease | bipolar disorder (implicated_via_orthology) | 1.09e-04 | 7 | 68 | 2 | DOID:3312 (implicated_via_orthology) | |
| Disease | sitting height ratio | 2.25e-04 | 51 | 68 | 3 | EFO_0007118 | |
| Disease | neuroblastoma (is_implicated_in) | 2.33e-04 | 10 | 68 | 2 | DOID:769 (is_implicated_in) | |
| Disease | cancer (implicated_via_orthology) | 3.89e-04 | 268 | 68 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome | 4.02e-04 | 13 | 68 | 2 | C0265338 | |
| Disease | high grade glioma (biomarker_via_orthology) | 5.39e-04 | 15 | 68 | 2 | DOID:3070 (biomarker_via_orthology) | |
| Disease | ischemia (implicated_via_orthology) | 6.96e-04 | 17 | 68 | 2 | DOID:326 (implicated_via_orthology) | |
| Disease | intraocular pressure measurement | 1.13e-03 | 509 | 68 | 6 | EFO_0004695 | |
| Disease | Colorectal Carcinoma | 1.15e-03 | 702 | 68 | 7 | C0009402 | |
| Disease | Neurodevelopmental Disorders | 1.31e-03 | 93 | 68 | 3 | C1535926 | |
| Disease | Bell's palsy | 1.71e-03 | 102 | 68 | 3 | EFO_0007167 | |
| Disease | Bilateral Wilms Tumor | 2.04e-03 | 29 | 68 | 2 | C2930471 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AYGSLQNPYGMTFQP | 1411 | O60241 | |
| GQLMRYQHPPEYGAA | 276 | Q4VCS5 | |
| YDRMQQLPAYQGEGP | 56 | P30988 | |
| GPSNLNGMYYPQRQN | 451 | O15123 | |
| ETAQMYPRPNMNLGY | 411 | Q5JTC6 | |
| QQMPPQYGQQGVSGY | 661 | Q8NFD5 | |
| GPQMSQYGPQGNYSR | 911 | Q8NFD5 | |
| AARNDMPYPYQNRQG | 1536 | Q8NFD5 | |
| QPGYDGKRNMYTAHP | 81 | Q9HCK5 | |
| ANPRAGLYLQQMPYP | 521 | Q8IZY2 | |
| YCNGNLGNMSELPPY | 86 | P43699 | |
| YPRGLVQPGMDQYGL | 791 | Q9H0J4 | |
| YQHGMVPPGREQYGQ | 841 | Q9H0J4 | |
| PFVPAYYGMVLQDGQ | 451 | Q96DU7 | |
| QQNYKRPMDGTYGPP | 1366 | O14497 | |
| YMYGSPGELRDRAPQ | 141 | P31274 | |
| VMYPTYGNGDPQNFK | 231 | P09237 | |
| SVNPYQMFGIYGPEQ | 1261 | Q9UKN7 | |
| RPVPGIRMYQVQYNS | 446 | Q9P244 | |
| PQGMPEGDLVYVNYA | 166 | Q04609 | |
| IFSLGYMPYPGRTNQ | 716 | P29376 | |
| QYGDPPIYVMENGAS | 401 | Q6UWM7 | |
| MSDAQDGPRVRYNPY | 61 | Q9UBU9 | |
| LLPGYYMNLNQNPRT | 151 | O14986 | |
| EQAPYGMQTQNYPKG | 201 | P15036 | |
| IKQEPGMYREGPTYQ | 316 | P50549 | |
| FLTMNPGYAGRQELP | 1946 | Q96JB1 | |
| GMPQYRNPFEKGDLY | 316 | O60884 | |
| GVKQYGPNSPYMRTL | 321 | P87889 | |
| GVKQYGPNSPYMRTL | 321 | Q9YNA8 | |
| GVKQYGPNSPYMRTL | 321 | P62683 | |
| GVKQYGPNSPYMRTL | 321 | P63145 | |
| GVKQYGPNSPYMRTL | 321 | Q7LDI9 | |
| GVKQYGPNSPYMRTL | 321 | P63130 | |
| GVKQYGPNSPYMRTL | 321 | P62685 | |
| GVKQYGPNSPYMRTL | 321 | P63126 | |
| GVKQYGPNSPYMRTL | 321 | P62684 | |
| NNPNYIKDPGMSGYQ | 221 | A4FU69 | |
| MPKSYLPQTVRQGGY | 901 | P40189 | |
| ERPNFAGYMYILPQG | 51 | P22914 | |
| DPPGYLYQGSDMNGQ | 1001 | Q4KMG0 | |
| PQLLQGVYAMGFNRP | 101 | Q9UMR2 | |
| APMLNPDGVYLGNYR | 266 | Q5VU57 | |
| NMFGQIQSPGYPDSY | 26 | P48740 | |
| YELQVRAGPMPGSSY | 196 | Q9HBE5 | |
| NKPYIYGPTSQGERM | 576 | P19447 | |
| GIYNMPSYILRTPEG | 281 | O00237 | |
| PEMEYNGNPESVGYK | 1121 | Q58EX2 | |
| DEGGPNSYPVYLMEQ | 491 | Q3MIW9 | |
| LPVGPAGGNQMLEQY | 181 | P22061 | |
| YGTELNQGDMKPPSY | 121 | O43815 | |
| VRDYRQSSNMQPPGY | 146 | Q3ZLR7 | |
| LVRNFGYPLGEMSQP | 361 | Q15750 | |
| SRNYPGMLYIPQDFN | 331 | Q1RMZ1 | |
| PQGARMQAYSNPGYS | 21 | Q8WZ73 | |
| LLPGYYMNLNQNPRT | 201 | O60331 | |
| NMPGYLRPETAQGIF | 291 | P41250 | |
| VYGMVPPNYCSQRPR | 261 | Q969X2 | |
| MDGLQPGYRQIQSPF | 266 | Q6UWI4 | |
| MCYPPIIQSGGNYNL | 241 | Q9Y5B9 | |
| GVKQYGPNSPYMRTL | 321 | P63128 | |
| PEGYMCVKAGRNPNY | 346 | P35498 | |
| VRDYRQSSNMQPPGY | 146 | P0C7V6 | |
| QGAAEPMGQQYYPDG | 261 | O75177 | |
| GQGYRPQGQKSNDPM | 451 | Q86XZ4 | |
| AGRSYNDLMQYPVFP | 2716 | Q8IZQ1 | |
| PRYMAPELLQGSYGT | 271 | Q99640 | |
| MLYAANPGQLFGRIP | 31 | Q9BRJ7 | |
| PSQQYNMPQGGGQHY | 211 | Q15532 | |
| DKYQMGDQNVYPGPI | 51 | Q9Y4E8 | |
| PYQPMSGNQALVYEG | 2041 | Q5JSZ5 | |
| LRYGMNPHQTPAQLY | 206 | P31939 | |
| GYDYSQQGRFVPPDM | 41 | Q969M3 | |
| GQESEYGNITYPPAM | 531 | P29350 | |
| GFSGDMYPRPEQYGQ | 166 | Q15915 | |
| MYPRPEQYGQVTSPR | 171 | Q15915 | |
| LYGENMPPQDAEIGY | 241 | P33981 | |
| EGPVSNQGYMPYLNR | 61 | Q9UH65 | |
| QPNPGVHYEYVIMGT | 516 | Q6ZMP0 | |
| DFLQGRMPGNPYSSN | 4361 | Q5T4S7 | |
| IRPYMSQNNGDPVMY | 351 | Q9P275 | |
| KAGPAQPYIQQSMYG | 226 | Q9ULJ6 | |
| DPGMGNLTYSNPSYR | 1756 | O75096 |